STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...

Dublin, March 06, 2023 (GLOBE NEWSWIRE) -- The "Genotoxicity Testing and Mutagenicity Testing Services Market: Distribution by Type of Assay, Assay / Test Offered, End User Industry and Key ...

DUBLIN--(BUSINESS WIRE)--The "Genotoxicity Testing and Mutagenicity Testing Services Market: Distribution by Type of Assay, Assay / Test Offered, End User Industry and Key Geographical Regions: ...

Gentronix entered into a three-year agreement to provide GlaxoSmithKline (GSK) with GreenScreen HC and BlueScreen HC genotoxicity assays. The reporter-based assays have demonstrated the ability to ...

The toxicological testing market is no stranger to the principle of the three Rs of research: replacement, reduction, and refinement. With that to guide us, we will review ways to fulfill these ...

Chemicals used in different applications induce genetic and epigenetic aberrations implicated in various diseases, including cancer. Researchers from Japan have developed a cell-based reporter assay ...

In conjunction with the University of Manchester, Gentronix has been granted a research award of £133,024 by the National Centre for the Replacement, Refinement and Reduction of Animals in Research ...

An international research team has developed an in vitro transcriptomic biomarker that can predict, with up to 90% accuracy, whether a drug candidate or other chemical compound is likely to cause the ...

The micronucleus (MN) assay is one of the most widely used genotoxicity biomarkers in aquatic organisms, providing an efficient measure of chromosomal DNA damage occurring as a result of either ...

Background: Many bacterial or mammalian cell-based test systems, such as the Ames test, chromosomal aberration assays, or gene mutation assays, are commonly used in developed countries to detect the ...